Many Americans rely on drugs, medical devices, and surgery at some point in their lives to combat sickness or disease. But despite medical advances, lifespans are shortening, cancer rates are skyrocketing, and rare diseases are becoming more widespread. Simultaneously, cutting-edge medical research is no longer seeking to address these alarming concerns. Instead, “medical science is…

Commentary President Joe Biden on Sept. 12 launched a new initiative designed to funnel an unspecified amount of cash into the U.S. biotechnology industry. The initiative’s aim is simple: to make the United States more efficient and reduce dependence on communist China in the biotech space. A noble goal, no doubt. However, to beat China, a country that seeks…

Commentary The Biden administration is boosting biotech. Big time. It’s leveraging $2 billion to turbocharge the bioeconomy in America for a market expected to add tens of trillions of dollars in value over the coming years. “Global industry is on the cusp of an industrial revolution powered by biotechnology,” according to a White House fact…

The U.S. fentanyl crisis is being helped along by a Chinese city. President Joe Biden signed an executive order to boost biotechnology. It’s an effort to compete with China, but Beijing is taking action, too. California is banning foreign governments and companies from buying U.S. farmland. Books about sheep and wolves put a group of…

President Joe Biden has signed an executive order meant to boost biotech production and research in the United States, with a senior administration official saying that the presidential action was prompted in part by aggressive investment in the sector by China, posing a risk to U.S. competitiveness. The White House announced on Sept. 12 that…

Earlier in June 2022, an 11-year-old girl in Hong Kong fell ill with myocarditis three weeks after getting vaccinated. She is currently in a stable condition after completing heart surgery.  According to the reports which Hong Kong’s Department of Health (DH) received, three elderly citizens had taken the same vaccination within 14 days before they…

Commentary We have most likely begun a cyclical bear market. Such things used to be fairly commonplace, along with the lesser 10–15 percent or so corrections within broad stock up-trends. Particularly since the start of the pandemic two years ago, the Federal Reserve has all but outlawed such moves with its BIG thumb on the…

News Analysis A growing number of biotech, genomics, and medtech firms with ties to the Chinese Communist Party (CCP) are operating in the United States, raising concerns about medical and genetic data security. With more than $1 trillion at its disposal, China’s sovereign wealth fund has over 33 percent of the world’s total sovereign wealth…

The broader market weakness spread into the biotech sector in the week ending Jan. 28, sending stocks lower. Johnson & Johnson got the ball rolling on large-cap biopharma earnings, with mixed results. The positive forward outlook, however, lent support to the stock. Edwards Lifesciences Corporation came under pressure following an earnings miss. Among other noteworthy developments,…

Tennis star Novak Djokovic and his wife own an 80 percent share in a Danish biotech firm developing a treatment for COVID-19 that does not involve vaccination, the company’s boss said on Wednesday. The Serbian native 34, and his wife Jelena, 35, bought a majority stake in QuantBioRes back in June 2020, just months into the pandemic, the company’s chief…